Randomised controlled trial: Extended-duration dabigatran is non-inferior to warfarin and more effective than placebo for symptomatic VTE

    Research output: Contribution to journalArticle

    1 Citation (Scopus)
    Original languageEnglish (US)
    Pages (from-to)29
    Number of pages1
    JournalEvidence-Based Medicine
    Volume19
    Issue number1
    DOIs
    StatePublished - 2014

    Fingerprint

    Benzimidazoles
    beta-Alanine
    Venous Thromboembolism
    Warfarin
    Randomized Controlled Trials
    Placebos
    Dabigatran

    ASJC Scopus subject areas

    • Medicine(all)

    Cite this

    @article{a7036b5a2e0c45b0920b48fc98501b6a,
    title = "Randomised controlled trial: Extended-duration dabigatran is non-inferior to warfarin and more effective than placebo for symptomatic VTE",
    author = "Timothy Liem and Thomas Deloughery",
    year = "2014",
    doi = "10.1136/eb-2013-101317",
    language = "English (US)",
    volume = "19",
    pages = "29",
    journal = "Evidence-Based Medicine",
    issn = "1356-5524",
    publisher = "BMJ Publishing Group",
    number = "1",

    }

    TY - JOUR

    T1 - Randomised controlled trial

    T2 - Extended-duration dabigatran is non-inferior to warfarin and more effective than placebo for symptomatic VTE

    AU - Liem, Timothy

    AU - Deloughery, Thomas

    PY - 2014

    Y1 - 2014

    UR - http://www.scopus.com/inward/record.url?scp=84895559308&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84895559308&partnerID=8YFLogxK

    U2 - 10.1136/eb-2013-101317

    DO - 10.1136/eb-2013-101317

    M3 - Article

    C2 - 23749602

    AN - SCOPUS:84895559308

    VL - 19

    SP - 29

    JO - Evidence-Based Medicine

    JF - Evidence-Based Medicine

    SN - 1356-5524

    IS - 1

    ER -